Home
Quanex Building Products
Quanex Building Products Announces Fourth Quarter and Full Year 2025 Results
Business
Dec 11 2025
22 min read

Quanex Building Products Announces Fourth Quarter and Full Year 2025 Results

news images

Net Sales Growth of ~44% Year-Over-Year 
$75 Million of Debt Repaid in Fiscal 2025
Cash Provided by Operating Activities Increased ~86% Year-Over-Year
Healthy Balance Sheet and Strong Liquidity
Integration of Transformative Acquisition Substantially Complete and Thesis Remains Intact

HOUSTON, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Quanex Building Products Corporation (NYSE:NX) (“Quanex” or the “Company”) today announced its results for the three months and twelve months ended October 31, 2025.

The Company reported the following selected financial results:

 

Three Months Ended October 31,

 

Twelve Months Ended October 31,

($ in millions, except per share data)

2025

 

2024

 

2025

 

2024

Net Sales

$489.8

 

$492.2

 

$1,837.6

 

$1,277.9

Gross Margin

$137.6

 

$117.1

 

$499.2

 

$305.6

Gross Margin %

28.1%

 

23.8%

 

27.2%

 

23.9%

Net income (loss)

$19.6

 

($13.9)

 

($250.8)

 

$33.1

Diluted EPS

$0.43

 

($0.30)

 

($5.43)

 

$0.90

 

 

 

 

 

 

 

 

Adjusted Net Income

$38.0

 

$38.5

 

$106.4

 

$97.5

Adjusted Diluted EPS

$0.83

 

$0.82

 

$2.30

 

$2.66

Adjusted EBITDA

$70.9

 

$81.1

 

$242.9

 

$182.4

Adjusted EBITDA Margin %

14.5%

 

16.5%

 

13.2%

 

14.3%

 

 

 

 

 

 

 

 

Cash Provided by Operating Activities

$88.3

 

$5.5

 

$164.9

 

$88.8

Free Cash Flow

$66.6

 

($8.2)

 

$102.3

 

$51.7

(See Non-GAAP Terminology Definitions and Disclaimers section, Non-GAAP Financial Measure Disclosure table, Selected Segment Data table and reconciliation tables for additional information)

George Wilson, Chairman, President and Chief Executive Officer, commented, “Our fiscal 2025 can be summarized by the successful integration of Tyman and the re-segmentation of our operating and reporting structure to align with our long-term strategic objectives, all while navigating a challenging macroeconomic environment. We believe the new segmentation represents a critical step in advancing our long-term Profitable Growth strategy and provides a solid framework to drive future revenue and margin expansion, which is consistent with the original thesis for the Tyman acquisition. Inflationary pressures, political instability, high interest rates, tariff uncertainty, housing affordability issues, and geopolitical tensions collectively weakened consumer confidence around the world, causing our end markets to decline meaningfully as compared to 2024. Despite these headwinds, we performed well and achieved another record year of safety performance, with both recordable incident and severity rates reaching historic lows.

“We continue to be encouraged by the overall resilience of the business in the current environment, demonstrated by our strong cash flow, which enabled us to repay a total of $75 million in bank debt in 2025. Our balance sheet remains healthy, and our liquidity improved further during the fourth quarter of 2025. While the integration of the Tyman business is substantially complete, we still believe there is a path to realizing approximately $45 million in cost synergies over time, above our initial projection of $30 million, which has been fully realized. In addition, we have made significant progress towards resolving the isolated operational issue at one of our window and door hardware plants in Mexico and we anticipate that the plant will be fully stabilized in the first half of fiscal 2026. Looking ahead, we continue to be optimistic about our prospects for profitable growth and value creation.”

Fourth Quarter and Fiscal 2025 Results Summary

Quanex reported net sales of $489.8 million during the three months ended October 31, 2025, which represents a decrease of 0.5% compared to $492.2 million for the same period of 2024, mainly due to lower volume. The Company reported net sales of $1.84 billion during the twelve months ended October 31, 2025, which represents an increase of 43.8% compared to $1.28 billion for the same period of 2024. The increase for the full year was driven by the contribution from the Tyman acquisition that closed on August 1, 2024. In its Hardware Solutions segment, Quanex reported an increase of 1.4% in net sales for the fourth quarter of 2025, mostly due to foreign exchange and tariff pass-throughs, and an increase of 96.7% in net sales for the full year. In its Extruded Solutions segment, Quanex reported a decrease of 6.4% in net sales for the fourth quarter of 2025, driven by lower volumes, and an increase of 15.5% in net sales for the full year. For its Custom Solutions segment, the Company reported an increase of 2.1% in net sales for the fourth quarter of 2025, largely due to improved pricing, and an increase of 25.5% in net sales for the full year. (See Sales Analysis table for additional information)

On a consolidated basis, the decrease in adjusted earnings for the fourth quarter of 2025 was mainly due to lower volumes related to ongoing macroeconomic uncertainty coupled with low consumer confidence and operational challenges related to Quanex’s window and door hardware plant in Monterrey, Mexico.   The increase in adjusted earnings for the full year 2025, was primary attributable to the contribution from the Tyman acquisition combined with the realization of related cost synergies.

Balance Sheet & Liquidity Update

As of October 31, 2025, the Company had total debt of $703.9 million and Quanex’s leverage ratio of Net Debt to LTM Adjusted EBITDA was unchanged at 2.6x, compared to the prior quarter. As of October 31, 2025, Quanex reported a LTM Net Loss of $250.8 million, mainly due to the non-cash goodwill impairment reported in the third quarter, and LTM Adjusted EBITDA of $242.9 million (See Non-GAAP Terminology Definitions and Disclaimers section, Net Debt Reconciliation table and Last Twelve Months Adjusted EBITDA Reconciliation table for additional information)

The Company’s liquidity increased to $372.4 million as of October 31, 2025, consisting of $76.0 million in cash on hand plus availability under its Senior Secured Revolving Credit Facility due 2029, less letters of credit outstanding.

Share Repurchases

Quanex’s Board authorized a $75 million share repurchase program in December of 2021. Repurchases under this program will be made in open market transactions or privately negotiated transactions, subject to market conditions, applicable legal requirements, and other relevant factors. The Company repurchased 199,712 shares of common stock for approximately $3.1 million at an average price of $15.58 per share during the three months ended October 31, 2025. Quanex repurchased 1,709,119 shares of common stock for approximately $32.4 million at an average price of $18.93 per share during the twelve months ended October 31, 2025. As of October 31, 2025, approximately $30.5 million remained under the existing share repurchase authorization.

Outlook

Mr. Wilson stated, “Our long-term view continues to be favorable as the underlying fundamentals for the residential housing market remain positive. We enter fiscal 2026 with a cautious outlook due to the ongoing macroeconomic challenges, but we are optimistic that demand for our products will improve as consumer confidence is restored over time. Our current view is that fiscal 2026 could be flat compared to fiscal 2025 from a revenue and EBITDA perspective, with puts and takes, but the first half of 2026 may be more challenged than the first half of 2025, which would imply a somewhat improved second half year-over-year.   Having said that, and consistent with the last few years, based on current macro indicators, recent conversations with our customers, limited transparency, and varying opinions on the macroeconomic outlook for 2026, we are again taking a measured approach to guidance. We believe it would be premature to give official guidance at this time and intend to re-visit guidance for 2026 when we report earnings for the first quarter. As macroeconomic uncertainty subsides and consumer confidence improves, we believe our team is well positioned to capitalize on pent-up demand. In the meantime, we will stay focused on the things that we can control, with an emphasis on generating cash to continue paying down debt and opportunistically repurchasing our stock.”

Conference Call and Webcast Information

The Company has also scheduled a conference call for Friday, December 12, 2025 at 11:00 a.m. ET (10:00 a.m. CT) to discuss the release. A link to the live audio webcast will be available on Quanex’s website at http://www.quanex.com in the Investors section under Presentations & Events.

Participants can pre-register for the conference call using the following link: https://register-conf.media-server.com/register/BI74e5fd99c2e14c3896a48692a347cd12

Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, it is recommended that participants dial into the conference call ten minutes ahead of the scheduled start time. A replay will be available for a limited time on the Company’s website at http://www.quanex.com in the Investors section under Presentations & Events.

About Quanex

Quanex is a global manufacturer with core capabilities and broad applications across various end markets. The Company currently collaborates and partners with leading OEMs to provide innovative solutions in the window, door, solar, refrigeration, custom mixing, building access and cabinetry markets.  Looking ahead, Quanex plans to leverage its material science expertise and process engineering to expand into adjacent markets.

Non-GAAP Terminology Definitions and Disclaimers

Adjusted Net Income (defined as net income further adjusted to exclude amortization of step-up for purchase price adjustments on inventory, asset impairment charges, transaction, advisory fees and reorganization costs, restructuring charges related to severance and disposal of software, amortization expense related to intangible assets, pension settlement refund and other net adjustments related to foreign currency transaction gain/loss and effective tax rates reflecting impacts of adjustments on a with and without basis) and Adjusted EPS are non-GAAP financial measures that Quanex believes provide a consistent basis for comparison between periods and more accurately reflects operational performance, as they are not influenced by certain income or expense items not affecting ongoing operations. EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net), Adjusted EBITDA and LTM Adjusted EBITDA (defined as EBITDA further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges and asset impairment charges) are non-GAAP financial measures that the Company uses to measure operational performance and assist with financial decision-making.  Net Debt is defined as total debt (outstanding balance on the revolving credit facility plus financial lease obligations) less cash and cash equivalents. The leverage ratio of Net Debt to LTM Adjusted EBITDA is a financial measure that the Company believes is useful to investors and financial analysts in evaluating Quanex’s leverage. In addition, with certain limited adjustments, this leverage ratio is the basis for a key covenant in the Company’s credit agreement.

Free Cash Flow is a non-GAAP measure calculated using cash provided by operating activities less capital expenditures. Quanex uses the Free Cash Flow metric to measure operational and cash management performance and assist with financial decision-making.   Free Cash Flow is measured before application of certain contractual commitments (including capital lease obligations), and accordingly is not a true measure of the Company’s residual cash flow available for discretionary expenditures. Quanex believes Free Cash Flow is useful to investors in understanding and evaluating the Company’s financial and cash management performance.

Quanex believes that the presented non-GAAP measures provide a consistent basis for comparison between periods and will assist investors in understanding the Company’s financial performance when comparing results to other investment opportunities.  The presented non-GAAP measures may not be the same as those used by other companies. Quanex does not intend for this information to be considered in isolation or as a substitute for other measures prepared in accordance with U.S. GAAP.

Forward Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995.   Statements that use the words “estimated,” “expect,” “could,” “should,” “believe,” “will,” “might,” or similar words reflecting future expectations or beliefs are forward-looking statements. The forward-looking statements include, but are not limited to, the following: the Company’s ability to resolve an isolated operational issue at its window and door hardware plant located in Monterrey, Mexico, timing estimates or any other expectations related to the acquisition of Tyman, Quanex’s future operating results, future financial condition, future uses of cash and other expenditures, expenses and tax rates, expectations relating to the Company’s industry, and Quanex’s future growth, including any guidance discussed in this press release. The statements and guidance set forth in this release are based on current expectations. Actual results or events may differ materially from this release. Therefore, you should not rely on any of these forward-looking statements. For a complete discussion of factors that may affect the Company’s future performance, please refer to Quanex’s Annual Report on Form 10-K for the fiscal year ended October 31, 2024, and the Company’s Quarterly Reports on Form 10-Q under the sections entitled “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors”. Any forward-looking statements in this press release are made as of the date hereof, and Quanex undertakes no obligation to update or revise any forward-looking statements, whether written or oral, to reflect new information, developments or events.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share data)
(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended October 31,

 

Twelve Months Ended October 31,

 

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

489,846

 

 

$

492,161

 

 

$

1,837,641

 

 

$

1,277,862

 

Cost of sales

 

 

352,284

 

 

 

375,111

 

 

 

1,338,413

 

 

 

972,238

 

Selling, general and administrative

 

 

69,008

 

 

 

86,891

 

 

 

277,261

 

 

 

190,470

 

Restructuring (credit) charges

 

 

(16

)

 

 

-

 

 

 

10,191

 

 

 

-

 

Depreciation and amortization

 

 

25,630

 

 

 

27,329

 

 

 

103,444

 

 

 

60,328

 

Goodwill impairment charges

 

 

-

 

 

 

-

 

 

 

302,284

 

 

 

-

 

Operating income (loss)

 

 

42,940

 

 

 

2,830

 

 

 

(193,952

)

 

 

54,826

 

Interest expense

 

 

(13,468

)

 

 

(17,697

)

 

 

(55,812

)

 

 

(20,593

)

Other, net

 

 

5,246

 

 

 

(2,671

)

 

 

7,171

 

 

 

7,849

 

Income (loss) before income taxes

 

 

34,718

 

 

 

(17,538

)

 

 

(242,593

)

 

 

42,082

 

Income tax (expense) benefit

 

 

(15,147

)

 

 

3,621

 

 

 

(8,213

)

 

 

(9,023

)

Net income (loss)

 

$

19,571

 

 

$

(13,917

)

 

$

(250,806

)

 

$

33,059

 

 

 

 

 

 

 

 

 

 

Earnings (loss) per common share, basic

 

$

0.43

 

 

$

(0.30

)

 

$

(5.43

)

 

$

0.91

 

Earnings (loss) per common share, diluted

 

$

0.43

 

 

$

(0.30

)

 

$

(5.43

)

 

$

0.90

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding:

 

 

 

 

 

 

 

Basic

 

 

45,502

 

 

 

47,015

 

 

 

46,170

 

 

 

36,416

 

Diluted

 

 

45,593

 

 

 

47,015

 

 

 

46,170

 

 

 

36,648

 

 

 

 

 

 

 

 

 

 

Cash dividends per share

 

$

0.08

 

 

$

0.08

 

 

$

0.32

 

 

$

0.32

 

 

 

 

 

 

 

 

 

 


QUANEX BUILDING PRODUCTS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)

 

 

 

 

 

October 31, 2025

 

October 31, 2024

ASSETS

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

76,018

 

 

$

97,744

 

Restricted Cash

 

2,100

 

 

 

5,251

 

Accounts receivable, net

 

205,384

 

 

 

197,689

 

Inventories

 

254,122

 

 

 

275,550

 

Income taxes receivable

 

-

 

 

 

5,937

 

Prepaid assets

 

32,387

 

 

 

23,419

 

Other current assets

 

3,764

 

 

 

5,678

 

Total current assets

 

573,775

 

 

 

611,268

 

Property, plant and equipment, net

 

411,591

 

 

 

402,466

 

Operating lease right-of-use assets

 

154,866

 

 

 

126,715

 

Deferred tax assets

 

2,706

 

 

 

3,845

 

Goodwill

 

271,346

 

 

 

574,711

 

Intangible assets, net

 

549,137

 

 

 

597,909

 

Other assets

 

4,812

 

 

 

2,874

 

Total assets

$

1,968,233

 

 

$

2,319,788

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

131,307

 

 

$

124,404

 

Accrued liabilities

 

95,155

 

 

 

103,623

 

Income taxes payable

 

12,076

 

 

 

6,620

 

Current maturities of long-term debt

 

27,561

 

 

 

25,745

 

Current operating lease liabilities

 

15,446

 

 

 

12,475

 

Total current liabilities

 

281,545

 

 

 

272,867

 

Long-term debt

 

665,268

 

 

 

737,198

 

Noncurrent operating lease liabilities

 

145,459

 

 

 

117,560

 

Deferred income taxes

 

135,993

 

 

 

162,304

 

Other liabilities

 

13,789

 

 

 

19,113

 

Total liabilities

 

1,242,054

 

 

 

1,309,042

 

Stockholders’ equity:

 

 

 

Common stock

 

512

 

 

 

513

 

Additional paid-in-capital

 

700,029

 

 

 

701,008

 

Retained earnings

 

164,710

 

 

 

430,405

 

Accumulated other comprehensive loss

 

(35,439

)

 

 

(46,428

)

Treasury stock at cost

 

(103,633

)

 

 

(74,752

)

Total stockholders’ equity

 

726,179

 

 

 

1,010,746

 

Total liabilities and stockholders' equity

$

1,968,233

 

 

$

2,319,788

 

 

 

 

 


CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
(In thousands)
(Unaudited)

 

 

 

 

 

Twelve Months Ended October 31,

 

 

2025

 

 

 

2024

 

Operating activities:

 

 

 

Net (loss) income

$

(250,806

)

 

$

33,059

 

Adjustments to reconcile net (loss) income to cash provided by operating activities:

 

 

 

Depreciation and amortization

 

103,444

 

 

 

60,328

 

Loss (gain) on disposition of capital assets

 

613

 

 

 

(5,218

)

Stock-based compensation

 

3,685

 

 

 

2,952

 

Deferred income tax

 

(18,535

)

 

 

(15,336

)

Goodwill impairment charge

 

302,284

 

 

 

-

 

Charge for deferred loan costs and debt discount

 

-

 

 

 

3,469

 

Gain on deal contingent foreign exchange forward currency contract

 

-

 

 

 

(6,512

)

Restructuring charges

 

4,561

 

 

 

-

 

Other, net

 

7,114

 

 

 

4,495

 

Changes in assets and liabilities:

 

 

 

(Increase) decrease in accounts receivable

 

(6,878

)

 

 

973

 

Decrease in inventory

 

23,553

 

 

 

33,484

 

(Increase) decrease in other current assets

 

(3,653

)

 

 

4,297

 

Increase (decrease) in accounts payable

 

3,313

 

 

 

(35,824

)

(Decrease) increase in accrued liabilities

 

(9,657

)

 

 

6,250

 

Increase in current income taxes payable

 

11,108

 

 

 

9,139

 

Decrease in other long-term liabilities

 

(4,693

)

 

 

(7,155

)

Other, net

 

(556

)

 

 

411

 

Cash provided by operating activities

 

164,897

 

 

 

88,812

 

Investing activities:

 

 

 

Business acquisition

 

-

 

 

 

(398,554

)

Capital expenditures

 

(62,642

)

 

 

(37,086

)

Proceeds from disposition of capital assets

 

634

 

 

 

15,046

 

Cash used for investing activities

 

(62,008

)

 

 

(420,594

)

Financing activities:

 

 

 

Borrowings under credit facilities

 

190,000

 

 

 

785,000

 

Repayments of credit facility borrowings

 

(265,000

)

 

 

(83,750

)

Debt issuance costs

 

-

 

 

 

(13,808

)

Repayments of other long-term debt

 

(4,045

)

 

 

(296,206

)

Common stock dividends paid

 

(14,889

)

 

 

(11,972

)

Issuance of common stock

 

214

 

 

 

573

 

Proceeds from deal contingent foreign exchange forward currency contract

 

-

 

 

 

6,512

 

Payroll tax paid to settle shares forfeited upon vesting of stock

 

(1,400

)

 

 

(1,193

)

Purchase of treasury stock

 

(32,360

)

 

 

-

 

Cash (used for) provided by financing activities

 

(127,480

)

 

 

385,156

 

Effect of exchange rate changes on cash and cash equivalents

 

(286

)

 

 

(8,853

)

(Decrease) Increase in cash, cash equivalents and restricted cash

 

(24,877

)

 

 

44,521

 

Cash, cash equivalents and restricted cash at beginning of period

 

102,995

 

 

 

58,474

 

Cash, cash equivalents and restricted cash at end of period

$

78,118

 

 

$

102,995

 

 

 

 

 


QUANEX BUILDING PRODUCTS CORPORATION
FREE CASH FLOW AND NET DEBT RECONCILIATION
(In thousands)
(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures.

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended October 31,

 

Twelve Months Ended October 31,

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Cash provided by operating activities

$88,254

 

 

$5,479

 

 

164,897

 

 

$88,812

 

Capital expenditures

(21,646

)

 

(13,651

)

 

(62,642

)

 

(37,086

)

Free Cash Flow

$66,608

 

 

($8,172

)

 

102,255

 

 

$51,726

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash.

 

 

 

 

 

 

 

 

 

 

 

 

 

As of October 31,

 

 

 

 

 

2025

 

 

2024

 

 

 

 

 

 

 

Term loan facility

$468,750

 

 

$493,750

 

 

 

 

 

 

 

Revolving credit facility

172,500

 

 

222,500

 

 

 

 

 

 

 

Finance lease obligations (1)

62,619

 

 

60,676

 

 

 

 

 

 

 

Total debt (2)

703,869

 

 

776,926

 

 

 

 

 

 

 

Less: Cash and cash equivalents

76,018

 

 

97,744

 

 

 

 

 

 

 

Net Debt

627,851

 

 

679,182

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Includes $56.4 million and $50.3 million in real estate lease liabilities considered finance leases under U.S. GAAP as of October 31, 2025 and 2024, respectively.

(2) Excludes outstanding letters of credit.

 

 

 

 

 

 

 

 

 

 

 

 


QUANEX BUILDING PRODUCTS CORPORATION
NON-GAAP FINANCIAL MEASURE DISCLOSURE
LAST TWELVE MONTHS ADJUSTED EBITDA RECONCILIATION
(In thousands, except per share data)
(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Last Twelve Months Adjusted EBITDA

 

Three Months Ended
October 31, 2025

 

Three Months Ended
July 31, 2025

 

Three Months Ended
April 30, 2025

 

Three Months Ended
January 31, 2025

 

Total

 

 

Reconciliation

 

Reconciliation

 

Reconciliation

 

Reconciliation

 

Reconciliation

Net income (loss) as reported

 

$

19,571

 

 

$

(276,007

)

 

$

20,515

 

$

(14,885

)

 

$

(250,806

)

Income tax expense (benefit)

 

 

15,147

 

 

 

(8,191

)

 

 

6,307

 

 

(5,050

)

 

 

8,213

 

Other, net

 

 

(5,246

)

 

 

(855

)

 

 

159

 

 

(1,229

)

 

 

(7,171

)

Interest expense

 

 

13,468

 

 

 

14,218

 

 

 

13,940

 

 

14,186

 

 

 

55,812

 

Depreciation and amortization

 

 

25,630

 

 

 

33,882

 

 

 

19,192

 

 

24,740

 

 

 

103,444

 

Asset impairment charges

 

 

-

 

 

 

302,284

 

 

 

-

 

 

-

 

 

 

302,284

 

EBITDA

 

 

68,570

 

 

 

65,331

 

 

 

60,113

 

 

17,762

 

 

 

211,776

 

Cost of sales (1),(2)

 

 

308

 

 

 

148

 

 

 

976

 

 

9,007

 

 

 

10,439

 

Selling, general and administrative (1),(3)

 

 

2,056

 

 

 

3,449

 

 

 

1,110

 

 

3,869

 

 

 

10,484

 

Restructuring (credit) charges (4)

 

 

(16

)

 

 

1,367

 

 

 

936

 

 

7,904

 

 

 

10,191

 

Adjusted EBITDA

 

$

70,918

 

 

$

70,295

 

 

$

63,135

 

$

38,542

 

 

$

242,890

 

 

 

 

 

 

 

 

 

 

 

 

(1) Expense related to plant closure/relocation.

 

 

 

 

 

 

 

 

 

 

(2) Amortization of step-up for purchase price adjustments on inventory.

 

 

 

 

 

 

 

 

(3) Transaction, advisory fees, reorganization costs and product recall expenses.

 

 

 

 

 

 

 

 

(4) Restructuring charges related to severance.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

QUANEX BUILDING PRODUCTS CORPORATION
NON-GAAP FINANCIAL MEASURE DISCLOSURE
(In thousands, except per share data)
(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Adjusted Net Income and Adjusted EPS

 

Three Months Ended
October 31, 2025

 

Three Months Ended
October 31, 2024

 

Twelve Months Ended
October 31, 2025

 

Twelve Months Ended
October 31, 2024

 

 

 

Net Income

 

Diluted EPS

 

Net Income

 

Diluted EPS

 

Net Income

 

Diluted EPS

 

Net Income

 

Diluted EPS

 

Net income (loss) as reported

 

$

19,571

 

 

$

0.43

 

 

$

(13,917

)

 

$

(0.30

)

 

$

(250,806

)

 

$

(5.43

)

 

$

33,059

 

 

$

0.90

 

 

Net income (loss) reconciling items from below

 

 

18,454

 

 

$

0.40

 

 

 

52,440

 

 

$

1.12

 

 

 

357,209

 

 

$

7.73

 

 

 

64,462

 

 

$

1.76

 

 

Adjusted net income and adjusted EPS

 

$

38,025

 

 

$

0.83

 

 

$

38,523

 

 

$

0.82

 

 

$

106,403

 

 

$

2.30

 

 

$

97,521

 

 

$

2.66

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Adjusted EBITDA

 

Three Months Ended
October 31, 2025

 

Three Months Ended
October 31, 2024

 

Twelve Months Ended
October 31, 2025

 

Twelve Months Ended
October 31, 2024

 

 

 

Reconciliation

 

 

 

Reconciliation

 

 

 

Reconciliation

 

 

 

Reconciliation

 

 

 

Net income (loss)as reported

 

$

19,571

 

 

 

 

$

(13,917

)

 

 

 

$

(250,806

)

 

 

 

$

33,059

 

 

 

 

Income tax expense (benefit)

 

 

15,147

 

 

 

 

 

(3,621

)

 

 

 

 

8,213

 

 

 

 

 

9,023

 

 

 

 

Other, net

 

 

(5,246

)

 

 

 

 

2,671

 

 

 

 

 

(7,171

)

 

 

 

 

(7,849

)

 

 

 

Interest expense

 

 

13,468

 

 

 

 

 

17,697

 

 

 

 

 

55,812

 

 

 

 

 

20,593

 

 

 

 

Depreciation and amortization

 

 

25,630

 

 

 

 

 

27,329

 

 

 

 

 

103,444

 

 

 

 

 

60,328

 

 

 

 

Asset impairment charges

 

 

-

 

 

 

 

 

-

 

 

 

 

 

302,284

 

 

 

 

 

-

 

 

 

 

EBITDA

 

 

68,570

 

 

 

 

 

30,159

 

 

 

 

 

211,776

 

 

 

 

 

115,154

 

 

 

 

EBITDA reconciling items from below

 

 

2,348

 

 

 

 

 

50,891

 

 

 

 

 

31,114

 

 

 

 

 

67,229

 

 

 

 

Adjusted EBITDA

 

$

70,918

 

 

 

 

$

81,050

 

 

 

 

$

242,890

 

 

 

 

$

182,383

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciling Items

 

Three Months Ended
October 31, 2025

 

Three Months Ended
October 31, 2024

 

Twelve Months Ended
October 31, 2025

 

Twelve Months Ended
October 31, 2024

 

 

 

Income Statement

 

Reconciling Items

 

Income Statement

 

Reconciling Items

 

Income Statement

 

Reconciling Items

 

Income Statement

 

Reconciling Items

 

Net sales

 

$

489,846

 

 

$

-

 

 

$

492,161

 

 

$

-

 

 

$

1,837,641

 

 

$

-

 

 

$

1,277,862

 

 

$

-

 

 

Cost of sales

 

 

352,284

 

 

 

(308

)

(1)

 

375,111

 

 

 

(29,363

)

(1),(2)

 

1,338,413

 

 

 

(10,439

)

(1),(2)

 

972,238

 

 

 

(31,501

)

(1),(2)

Selling, general and administrative

 

 

69,008

 

 

 

(2,056

)

(1),(3)

 

86,891

 

 

 

(21,528

)

(1),(3),(4)

 

277,261

 

 

 

(10,484

)

(1),(3)

 

190,470

 

 

 

(35,728

)

(1),(3),(4)

Restructuring credit (charges)

 

 

(16

)

 

 

16

 

(5)

 

-

 

 

 

-

 

 

 

10,191

 

 

 

(10,191

)

(5)

 

-

 

 

 

-

 

(5)

EBITDA

 

 

68,570

 

 

 

2,348

 

 

 

30,159

 

 

 

50,891

 

 

 

211,776

 

 

 

31,114

 

 

 

115,154

 

 

 

67,229

 

 

Goowill impairment charges

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

302,284

 

 

 

(302,284

)

(6)

 

-

 

 

 

-

 

 

Depreciation and amortization

 

 

25,630

 

 

 

(9,839

)

(7)

 

27,329

 

 

 

(12,623

)

(7)

 

103,444

 

 

 

(46,547

)

(7)

 

60,328

 

 

 

(21,605

)

(7)

Operating income (loss)

 

 

42,940

 

 

 

12,187

 

 

 

2,830

 

 

 

63,514

 

 

 

(193,952

)

 

 

379,945

 

 

 

54,826

 

 

 

88,834

 

 

Interest expense

 

 

(13,468

)

 

 

-

 

 

 

(17,697

)

 

 

-

 

 

 

(55,812

)

 

 

-

 

 

 

(20,593

)

 

 

-

 

 

Other, net

 

 

5,246

 

 

 

238

 

(8)

 

(2,671

)

 

 

3,271

 

(8)

 

7,171

 

 

 

120

 

(8)

 

7,849

 

 

 

(6,738

)

(8)

Income (loss) before income taxes

 

 

34,718

 

 

 

12,425

 

 

 

(17,538

)

 

 

66,785

 

 

 

(242,593

)

 

 

380,065

 

 

 

42,082

 

 

 

82,096

 

 

Income tax (expense) benefit

 

 

(15,147

)

 

 

6,029

 

(9)

 

3,621

 

 

 

(14,345

)

(9)

 

(8,213

)

 

 

(22,856

)

(9)

 

(9,023

)

 

 

(17,634

)

(9)

Net income (loss)

 

$

19,571

 

 

$

18,454

 

 

$

(13,917

)

 

$

52,440

 

 

$

(250,806

)

 

$

357,209

 

 

$

33,059

 

 

$

64,462

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings (loss) per share

 

$

0.43

 

 

 

 

$

(0.30

)

 

 

 

$

(5.43

)

 

 

 

$

0.90

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Expense related to plant closure/relocation.

(2) Amortization of step-up for purchase price adjustments on inventory.

(3) Transaction, advisory fees, reorganization costs and product recall expenses.

(4) Amortization of step-up for purchase price adjustments on accounts receivable.

(5) Restructuring credit (charges) related to severance and disposal of software.

(6) Goodwill impairment.

(7) Amortization expense related to intangible assets and onetime deprecation adjustment.

(8) Pension settlement refund and foreign currency transaction gains.

(9) Tax impact of net income reconciling items.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


QUANEX BUILDING PRODUCTS CORPORATION
SELECTED SEGMENT DATA
(In thousands)
(Unaudited)

 

 

 

 

 

 

 

 

 

 

This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments.

 

Hardware Solutions

 

Extruded Solutions

 

Custom Solutions

 

Unallocated Corp & Other

 

Total

Three months ended October 31, 2025

 

 

 

 

 

 

 

 

 

Net sales

$

226,883

 

 

$

168,603

 

 

$

103,401

 

 

$

(9,041

)

 

$

489,846

 

Cost of sales

 

168,881

 

 

 

114,227

 

 

 

78,561

 

 

 

(9,385

)

 

 

352,284

 

Gross Margin

 

58,002

 

 

 

54,376

 

 

 

24,840

 

 

 

344

 

 

 

137,562

 

Gross Margin %

 

25.6

%

 

 

32.3

%

 

 

24.0

%

 

 

 

 

28.1

%

Selling, general and administrative (1)

 

29,439

 

 

 

22,795

 

 

 

14,117

 

 

 

2,657

 

 

 

69,008

 

Restructuring (credit) charges

 

(219

)

 

 

-

 

 

 

179

 

 

 

24

 

 

 

(16

)

Depreciation and amortization

 

12,863

 

 

 

7,138

 

 

 

5,555

 

 

 

74

 

 

 

25,630

 

Operating income (loss)

 

15,919

 

 

 

24,443

 

 

 

4,989

 

 

 

(2,411

)

 

 

42,940

 

Depreciation and amortization

 

12,863

 

 

 

7,138

 

 

 

5,555

 

 

 

74

 

 

 

25,630

 

EBITDA

 

28,782

 

 

 

31,581

 

 

 

10,544

 

 

 

(2,337

)

 

 

68,570

 

Expense related to plant relocation (Cost of sales)

 

308

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

308

 

Credit related to plant relocation (SG&A)

 

(25

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(25

)

Transaction, advisory fees, reorganization costs, and product recall expenses

 

113

 

 

 

87

 

 

 

31

 

 

 

1,850

 

 

 

2,081

 

Restructuring (credit) charges related to severance

 

(219

)

 

 

-

 

 

 

179

 

 

 

24

 

 

 

(16

)

Adjusted EBITDA

$

28,959

 

 

$

31,668

 

 

$

10,754

 

 

$

(463

)

 

$

70,918

 

Adjusted EBITDA Margin %

 

12.8

%

 

 

18.8

%

 

 

10.4

%

 

 

 

 

14.5

%

 

 

 

 

 

 

 

 

 

 

Three months ended October 31, 2024

 

 

 

 

 

 

 

 

 

Net sales

$

223,712

 

 

$

180,135

 

 

$

101,240

 

 

$

(12,926

)

 

$

492,161

 

Cost of sales

 

183,427

 

 

 

126,653

 

 

 

77,746

 

 

 

(12,715

)

 

 

375,111

 

Gross Margin

 

40,285

 

 

 

53,482

 

 

 

23,494

 

 

 

(211

)

 

 

117,050

 

Gross Margin %

 

18.0

%

 

 

29.7

%

 

 

23.2

%

 

 

 

 

23.8

%

Selling, general and administrative (1)

 

32,860

 

 

 

12,367

 

 

 

11,612

 

 

 

30,052

 

 

 

86,891

 

Restructuring charges

 

 

 

 

 

 

 

 

 

-

 

Depreciation and amortization

 

13,049

 

 

 

8,503

 

 

 

5,663

 

 

 

114

 

 

 

27,329

 

Operating (loss) income

 

(5,624

)

 

 

32,612

 

 

 

6,219

 

 

 

(30,377

)

 

 

2,830

 

Depreciation and amortization

 

13,049

 

 

 

8,503

 

 

 

5,663

 

 

 

114

 

 

 

27,329

 

EBITDA

 

7,425

 

 

 

41,115

 

 

 

11,882

 

 

 

(30,263

)

 

 

30,159

 

Expense related to plant closure (Cost of sales)

 

-

 

 

 

887

 

 

 

-

 

 

 

-

 

 

 

887

 

Gain related to plant closure (SG&A)

 

-

 

 

 

(5,299

)

 

 

-

 

 

 

-

 

 

 

(5,299

)

Amortization of step-up for purchase price adjustments on inventory and accounts receivable

 

24,240

 

 

 

1,137

 

 

 

3,699

 

 

 

-

 

 

 

29,076

 

Transaction and advisory fees

 

268

 

 

 

88

 

 

 

-

 

 

 

25,871

 

 

 

26,227

 

Adjusted EBITDA

$

31,933

 

 

$

37,928

 

 

$

15,581

 

 

$

(4,392

)

 

$

81,050

 

Adjusted EBITDA Margin %

 

14.3

%

 

 

21.1

%

 

 

15.4

%

 

 

 

 

16.5

%

 

 

 

 

 

 

 

 

 

 

Twelve months ended October 31, 2025

 

 

 

 

 

 

 

 

 

Net sales

$

841,674

 

 

$

646,627

 

 

$

388,210

 

 

$

(38,870

)

 

$

1,837,641

 

Cost of sales

 

635,481

 

 

 

440,141

 

 

 

298,316

 

 

 

(35,525

)

 

 

1,338,413

 

Gross Margin

 

206,193

 

 

 

206,486

 

 

 

89,894

 

 

 

(3,345

)

 

 

499,228

 

Gross Margin %

 

24.5

%

 

 

31.9

%

 

 

23.2

%

 

 

 

 

27.2

%

Selling, general and administrative (1)

 

128,009

 

 

 

83,716

 

 

 

48,273

 

 

 

17,263

 

 

 

277,261

 

Restructuring charges

 

7,936

 

 

 

34

 

 

 

205

 

 

 

2,016

 

 

 

10,191

 

Depreciation and amortization

 

51,681

 

 

 

29,204

 

 

 

21,248

 

 

 

1,311

 

 

 

103,444

 

Goodwill impairment charges

 

163,198

 

 

 

54,934

 

 

 

84,152

 

 

 

-

 

 

 

302,284

 

Operating (loss) income

 

(144,631

)

 

 

38,598

 

 

 

(63,984

)

 

 

(23,935

)

 

 

(193,952

)

Depreciation and amortization

 

51,681

 

 

 

29,204

 

 

 

21,248

 

 

 

1,311

 

 

 

103,444

 

Asset impairment charges

 

163,198

 

 

 

54,934

 

 

 

84,152

 

 

 

-

 

 

 

302,284

 

EBITDA

 

70,248

 

 

 

122,736

 

 

 

41,416

 

 

 

(22,624

)

 

 

211,776

 

Expense related to plant relocation (Cost of sales)

 

1,432

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,432

 

Expense related to plant relocation (SG&A)

 

221

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

221

 

Amortization of step-up for purchase price adjustments on inventory

 

7,453

 

 

 

365

 

 

 

1,189

 

 

 

-

 

 

 

9,007

 

Transaction, advisory fees, reorganization costs, and product recall expenses

 

1,510

 

 

 

263

 

 

 

81

 

 

 

8,409

 

 

 

10,263

 

Restructuring charges related to severance and disposal of software

 

7,936

 

 

 

34

 

 

 

205

 

 

 

2,016

 

 

 

10,191

 

Adjusted EBITDA

$

88,800

 

 

$

123,398

 

 

$

42,891

 

 

$

(12,199

)

 

$

242,890

 

Adjusted EBITDA Margin %

 

10.6

%

 

 

19.1

%

 

 

11.0

%

 

 

 

 

13.2

%

 

 

 

 

 

 

 

 

 

 

Twelve months ended October 31, 2024

 

 

 

 

 

 

 

 

 

Net sales

$

427,839

 

 

$

559,995

 

 

$

309,441

 

 

$

(19,413

)

 

$

1,277,862

 

Cost of sales

 

349,379

 

 

 

389,760

 

 

 

252,111

 

 

 

(19,012

)

 

 

972,238

 

Gross Margin

 

78,460

 

 

 

170,235

 

 

 

57,330

 

 

 

(401

)

 

 

305,624

 

Gross Margin %

 

18.3

%

 

 

30.4

%

 

 

18.5

%

 

 

 

 

23.9

%

Selling, general and administrative (1)

 

51,564

 

 

 

58,100

 

 

 

31,068

 

 

 

49,738

 

 

 

190,470

 

Restructuring charges

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Depreciation and amortization

 

16,580

 

 

 

25,119

 

 

 

18,348

 

 

 

281

 

 

 

60,328

 

Operating income (loss)

 

10,316

 

 

 

87,016

 

 

 

7,914

 

 

 

(50,420

)

 

 

54,826

 

Depreciation and amortization

 

16,580

 

 

 

25,119

 

 

 

18,348

 

 

 

281

 

 

 

60,328

 

EBITDA

 

26,896

 

 

 

112,135

 

 

 

26,262

 

 

 

(50,139

)

 

 

115,154

 

Expense related to plant closure (Cost of sales)

 

-

 

 

 

3,025

 

 

 

-

 

 

 

-

 

 

 

3,025

 

Gain related to plant closure (SG&A)

 

-

 

 

 

(4,196

)

 

 

-

 

 

 

-

 

 

 

(4,196

)

Amortization of step-up for purchase price adjustments on inventory and accounts receivable

 

24,240

 

 

 

1,137

 

 

 

3,699

 

 

 

-

 

 

 

29,076

 

Transaction and advisory fees

 

268

 

 

 

88

 

 

 

-

 

 

 

38,968

 

 

 

39,324

 

Adjusted EBITDA

$

51,404

 

 

$

112,189

 

 

$

29,961

 

 

$

(11,171

)

 

$

182,383

 

Adjusted EBITDA Margin %

 

12.0

%

 

 

20.0

%

 

 

9.7

%

 

 

 

 

14.3

%

 

 

 

 

 

 

 

 

 

 

(1) Includes stock-based compensation (credit) expense for the three and twelve months ended October 31, 2025, respectively of ($1.2) million and $2.4 million, and $2.0 million and $7.4 million for the comparable prior year periods.

 

 

 

 

 

 

 

 

 

 


QUANEX BUILDING PRODUCTS CORPORATION
SELECTED SEGMENT DATA RECONCILIATION
(In thousands)
(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

This table reconciles our segment presentation, as previously reported in Exhibit 99.1 to our Current Report Form 8-K dated December 12, 2024 for the three and twelve months ended October 31, 2024, to the current presentation.

 

 

NA Fenestration

 

EU Fenestration

 

NA Cabinet Components

 

Tyman

 

Unallocated Corp & Other

 

Total

Three months ended October 31, 2024

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

172,031

 

 

$

65,075

 

 

$

52,761

 

 

$

203,435

 

 

$

(1,141

)

 

$

492,161

 

Cost of sales

 

 

127,448

 

 

 

40,258

 

 

 

44,136

 

 

 

163,946

 

 

 

(677

)

 

 

375,111

 

Gross Margin

 

 

44,583

 

 

 

24,817

 

 

 

8,625

 

 

 

39,489

 

 

 

(464

)

 

 

117,050

 

Gross Margin %

 

 

25.9

%

 

 

38.1

%

 

 

16.3

%

 

 

19.4

%

 

 

 

 

23.8

%

Selling, general and administrative

 

 

10,072

 

 

 

8,310

 

 

 

5,373

 

 

 

44,453

 

 

 

18,683

 

 

 

86,891

 

Depreciation and amortization

 

 

5,107

 

 

 

2,715

 

 

 

3,004

 

 

 

16,438

 

 

 

65

 

 

 

27,329

 

Operating income (loss)

 

 

29,404

 

 

 

13,792

 

 

 

248

 

 

 

(21,402

)

 

 

(19,212

)

 

 

2,830

 

Depreciation and amortization

 

 

5,107

 

 

 

2,715

 

 

 

3,004

 

 

 

16,438

 

 

 

65

 

 

 

27,329

 

EBITDA

 

 

34,511

 

 

 

16,507

 

 

 

3,252

 

 

 

(4,964

)

 

 

(19,147

)

 

 

30,159

 

Expense related to plant closure (Cost of sales)

 

 

887

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

887

 

Net gain related to plant closure (SG&A)

 

 

(5,299

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(5,299

)

Amortization of step-up for purchase price adjustments on inventory and accounts receivable

 

 

-

 

 

 

-

 

 

 

-

 

 

 

29,076

 

 

 

-

 

 

 

29,076

 

Transaction and advisory fees

 

 

-

 

 

 

-

 

 

 

-

 

 

 

10,359

 

 

 

15,868

 

 

 

26,227

 

Adjusted EBITDA

 

$

30,099

 

 

$

16,507

 

 

$

3,252

 

 

$

34,471

 

 

$

(3,279

)

 

$

81,050

 

Adjusted EBITDA Margin %

 

 

17.5

%

 

 

25.4

%

 

 

6.2

%

 

 

16.9

%

 

 

 

 

16.5

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hardware Solutions(1)

 

Extruded Solutions(2)

 

Custom Solutions(3)

 

Tyman

 

Unallocated Corp & Other

 

Total

Three months ended October 31, 2024

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

223,712

 

 

$

180,135

 

 

$

101,240

 

 

$

-

 

 

$

(12,926

)

 

$

492,161

 

Cost of sales

 

 

183,427

 

 

 

126,653

 

 

 

77,746

 

 

 

-

 

 

 

(12,715

)

 

 

375,111

 

Gross Margin

 

 

40,285

 

 

 

53,482

 

 

 

23,494

 

 

 

-

 

 

 

(211

)

 

 

117,050

 

Gross Margin %

 

 

18.0

%

 

 

29.7

%

 

 

23.2

%

 

 

 

 

 

 

23.8

%

Selling, general and administrative

 

 

32,860

 

 

 

12,367

 

 

 

11,612

 

 

 

-

 

 

 

30,052

 

 

 

86,891

 

Depreciation and amortization

 

 

13,049

 

 

 

8,503

 

 

 

5,663

 

 

 

-

 

 

 

114

 

 

 

27,329

 

Operating income

 

 

(5,624

)

 

 

32,612

 

 

 

6,219

 

 

 

-

 

 

 

(30,377

)

 

 

2,830

 

Depreciation and amortization

 

 

13,049

 

 

 

8,503

 

 

 

5,663

 

 

 

-

 

 

 

114

 

 

 

27,329

 

EBITDA

 

 

7,425

 

 

 

41,115

 

 

 

11,882

 

 

 

-

 

 

 

(30,263

)

 

 

30,159

 

Expense related to plant closure (Cost of sales)

 

 

-

 

 

 

887

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

887

 

Net gain related to plant closure (SG&A)

 

 

-

 

 

 

(5,299

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(5,299

)

Amortization of step-up for purchase price adjustments on inventory and accounts receivable

 

 

24,240

 

 

 

1,137

 

 

 

3,699

 

 

 

-

 

-

 

-

 

 

 

29,076

 

Transaction and advisory fees

 

 

268

 

 

 

88

 

 

 

-

 

 

 

-

 

 

 

25,871

 

 

 

26,227

 

Adjusted EBITDA

 

$

31,933

 

 

$

37,928

 

 

$

15,581

 

 

$

-

 

 

$

(4,392

)

 

$

81,050

 

Adjusted EBITDA Margin %

 

 

14.3

%

 

 

21.1

%

 

 

15.4

%

 

 

 

 

 

 

16.5

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NA Fenestration

 

EU Fenestration

 

NA Cabinet Components

 

Tyman

 

Unallocated Corp & Other

 

Total

Twelve months ended October 31, 2024

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

650,058

 

 

$

230,712

 

 

$

198,424

 

 

$

203,435

 

 

$

(4,767

)

 

$

1,277,862

 

Cost of sales

 

 

498,378

 

 

 

144,585

 

 

 

168,414

 

 

 

163,946

 

 

 

(3,085

)

 

 

972,238

 

Gross Margin

 

 

151,680

 

 

 

86,127

 

 

 

30,010

 

 

 

39,489

 

 

 

(1,682

)

 

 

305,624

 

Gross Margin %

 

 

23.3

%

 

 

37.3

%

 

 

15.1

%

 

 

19.4

%

 

 

 

 

23.9

%

Selling, general and administrative

 

 

56,630

 

 

 

31,318

 

 

 

20,727

 

 

 

44,453

 

 

 

37,342

 

 

 

190,470

 

Depreciation and amortization

 

 

20,994

 

 

 

10,420

 

 

 

12,244

 

 

 

16,438

 

 

 

232

 

 

 

60,328

 

Operating income (loss)

 

 

74,056

 

 

 

44,389

 

 

 

(2,961

)

 

 

(21,402

)

 

 

(39,256

)

 

 

54,826

 

Depreciation and amortization

 

 

20,994

 

 

 

10,420

 

 

 

12,244

 

 

 

16,438

 

 

 

232

 

 

 

60,328

 

EBITDA

 

 

95,050

 

 

 

54,809

 

 

 

9,283

 

 

 

(4,964

)

 

 

(39,024

)

 

 

115,154

 

Expense related to plant closure (Cost of sales)

 

 

3,025

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

3,025

 

Net gain related to plant closure (SG&A)

 

 

(4,196

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(4,196

)

Amortization of step-up for purchase price adjustments on inventory and accounts receivable

 

 

-

 

 

 

-

 

 

 

-

 

 

 

29,076

 

 

 

-

 

 

 

29,076

 

Transaction and advisory fees

 

 

-

 

 

 

-

 

 

 

-

 

 

 

10,359

 

 

 

28,965

 

 

 

39,324

 

Adjusted EBITDA

 

$

93,879

 

 

$

54,809

 

 

$

9,283

 

 

$

34,471

 

 

$

(10,059

)

 

$

182,383

 

Adjusted EBITDA Margin %

 

 

14.4

%

 

 

23.8

%

 

 

4.7

%

 

 

16.9

%

 

 

 

 

14.3

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hardware Solutions(1)

 

Extruded Solutions(2)

 

Custom Solutions(3)

 

Tyman

 

Unallocated Corp & Other

 

Total

Twelve months ended October 31, 2024

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

427,839

 

 

$

559,995

 

 

$

309,441

 

 

$

-

 

 

$

(19,413

)

 

$

1,277,862

 

Cost of sales

 

 

349,379

 

 

 

389,760

 

 

 

252,111

 

 

 

-

 

 

 

(19,012

)

 

 

972,238

 

Gross Margin

 

 

78,460

 

 

 

170,235

 

 

 

57,330

 

 

 

-

 

 

 

(401

)

 

 

305,624

 

Gross Margin %

 

 

18.3

%

 

 

30.4

%

 

 

18.5

%

 

 

 

 

 

 

23.9

%

Selling, general and administrative

 

 

51,564

 

 

 

58,100

 

 

 

31,068

 

 

 

-

 

 

 

49,738

 

 

 

190,470

 

Depreciation and amortization

 

 

16,580

 

 

 

25,119

 

 

 

18,348

 

 

 

-

 

 

 

281

 

 

 

60,328

 

Operating income (loss)

 

 

10,316

 

 

 

87,016

 

 

 

7,914

 

 

 

-

 

 

 

(50,420

)

 

 

54,826

 

Depreciation and amortization

 

 

16,580

 

 

 

25,119

 

 

 

18,348

 

 

 

-

 

 

 

281

 

 

 

60,328

 

EBITDA

 

 

26,896

 

 

 

112,135

 

 

 

26,262

 

 

 

-

 

 

 

(50,139

)

 

 

115,154

 

Loss on damage to manufacturing facilities (Cost of sales)

 

 

-

 

 

 

3,025

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

3,025

 

Net gain related to plant closure (SG&A)

 

 

-

 

 

 

(4,196

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(4,196

)

Amortization of step-up for purchase price adjustments on inventory and accounts receivable

 

 

24,240

 

 

 

1,137

 

 

 

3,699

 

 

 

-

 

 

 

-

 

 

 

29,076

 

Transaction and advisory fees

 

 

268

 

 

 

88

 

 

 

-

 

 

 

-

 

 

 

38,968

 

 

 

39,324

 

Adjusted EBITDA

 

$

51,404

 

 

$

112,189

 

 

$

29,961

 

 

$

-

 

 

$

(11,171

)

 

$

182,383

 

Adjusted EBITDA Margin %

 

 

12.0

%

 

 

20.0

%

 

 

9.7

%

 

 

 

 

 

 

14.3

%

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Contains a portion of the previously reported NA Fenestration segment.

(2) Contains a portion of the NA Fenestration segment and the EU Fenestration segment.

(3) Contains a portion of the NA Fenestration segment and the NA Cabinet Components segment.

 

 

 

 

 

 

 

 

 

 

 

 

 

QUANEX BUILDING PRODUCTS CORPORATION
SALES ANALYSIS
(In thousands)
(Unaudited)



 

 

 

 

 

 

 

 

 

 

 

Three Months Ended October 31,

 

Twelve Months Ended October 31,

 

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

 

 

 

 

 

 

 

 

 

Hardware Solutions:(1)

 

 

 

 

 

 

 

 

Window and door hardware

$

141,303

 

 

$

146,187

 

 

$

552,825

 

 

$

146,187

 

 

Screens

 

77,545

 

 

 

75,677

 

 

 

280,814

 

 

 

279,804

 

 

Other

 

8,035

 

 

 

1,848

 

 

 

8,035

 

 

 

1,848

 

 

 

$

226,883

 

 

$

223,712

 

 

$

841,674

 

 

$

427,839

 

Extruded Solutions:(2)

 

 

 

 

 

 

 

 

Window profiles

$

73,526

 

 

$

62,058

 

 

$

278,399

 

 

$

255,816

 

 

Seals and gaskets

 

18,601

 

 

 

21,321

 

 

 

80,916

 

 

 

21,321

 

 

Spacers

 

52,673

 

 

 

51,714

 

 

 

199,217

 

 

 

198,475

 

 

Solar

 

6,245

 

 

 

9,598

 

 

 

24,080

 

 

 

25,672

 

 

Flashing Tape

 

3,074

 

 

 

4,751

 

 

 

9,825

 

 

 

18,263

 

 

Window and door hardware

 

10,032

 

 

 

11,177

 

 

 

39,726

 

 

 

11,177

 

 

Other

 

4,452

 

 

 

19,516

 

 

 

14,464

 

 

 

29,271

 

 

 

$

168,603

 

 

$

180,135

 

 

$

646,627

 

 

$

559,995

 

Custom Solutions:(3)

 

 

 

 

 

 

 

 

Wood solutions

$

51,648

 

 

$

52,761

 

 

$

200,104

 

 

$

198,424

 

 

Access solutions

 

27,746

 

 

 

25,792

 

 

 

101,904

 

 

 

25,792

 

 

Mixing solutions

 

24,007

 

 

 

22,687

 

 

 

86,202

 

 

 

85,225

 

 

 

$

103,401

 

 

$

101,240

 

 

$

388,210

 

 

$

309,441

 

 

 

 

 

 

 

 

 

 

Unallocated Corporate & Other:

 

 

 

 

 

 

 

 

Eliminations

$

(9,041

)

 

$

(12,926

)

 

$

(38,870

)

 

$

(19,413

)

 

 

$

(9,041

)

 

$

(12,926

)

 

$

(38,870

)

 

$

(19,413

)

 

 

 

 

 

 

 

 

 

Net Sales

$

489,846

 

 

$

492,161

 

 

$

1,837,641

 

 

$

1,277,862

 

 

 

 

 

 

 

 

 

 

(1) Reflects an increase of $2.5 million in revenue associated with foreign currency exchange rate impacts for the three and twelve months ended October 31, 2025, respectively.

(2) Reflects an increase of $2.5 million and $5.4 million in revenue associated with foreign currency exchange rate impacts for the three and twelve months ended October 31, 2025, respectively.

(3) Reflects an increase of $0.2 million in revenue associated with foreign currency exchange rate impacts for the three and twelve months ended October 31, 2025, respectively.

 

 

 

 

 

 

 

 

 



Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern